Related Experiment Video

Updated: Jun 22, 2026

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Functionally active toll-like receptor 3 on human primary and metastatic cancer cells

T Matijevic1, M Marjanovic, J Pavelic

  • 1Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia.

Scandinavian Journal of Immunology
|June 16, 2009
PubMed

Insights

Toll-like receptor 3 (TLR3) is expressed in tumor cell lines, but only functional in Detroit 562 cells. Poly I:C treatment of these cells triggers apoptosis, indicating potential for cancer therapy research.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are crucial in pathogen recognition and immune response.
  • Toll-like receptor 3 (TLR3) plays a role in innate immunity.
  • Understanding TLR3 expression and function in tumor cells is vital for therapeutic strategies.

Purpose of the Study:

  • To investigate TLR3 expression and functionality in selected cancer cell lines.
  • To determine the cellular response of these cell lines to polyinosine:polycytidylic acid (poly I:C) stimulation.
  • To evaluate the potential of TLR3 agonists in cancer therapy.

Main Methods:

  • Real-time PCR and flow cytometry for TLR3 expression analysis.
  • ELISA for cytokine secretion assessment (IL-6, IL-12p40, IL-8, IL-1alpha).
  • Annexin-V apoptosis assay to detect programmed cell death.

Main Results:

  • All tested cell lines (SW480, SW620, FaDu, Detroit 562) express TLR3 at mRNA and protein levels.
  • TLR3 functionality was confirmed only in Detroit 562 cells, evidenced by IL-6 secretion upon poly I:C treatment.
  • Poly I:C induced cell growth inhibition, upregulated pro-inflammatory cytokines, and triggered apoptosis in Detroit 562 cells.

Conclusions:

  • Detroit 562 cell line exhibits functional TLR3, responding to poly I:C with apoptosis induction.
  • Significant differences in TLR3 functionality exist between primary (FaDu) and metastatic (Detroit 562) pharyngeal carcinoma cell lines.
  • The Detroit 562 cell line serves as a promising model for developing TLR3-targeted cancer therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...